TOPCON 3D OCT-1000 OPTICAL COHERENCE TOMOGRAPHY SYSTEM
K063388 · Topcon Corp. · OBO · Jun 22, 2007 · Ophthalmic
Device Facts
| Record ID | K063388 |
| Device Name | TOPCON 3D OCT-1000 OPTICAL COHERENCE TOMOGRAPHY SYSTEM |
| Applicant | Topcon Corp. |
| Product Code | OBO · Ophthalmic |
| Decision Date | Jun 22, 2007 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 886.1570 |
| Device Class | Class 2 |
Intended Use
The Topcon 3D OCT-1000 is a non-contact ophthalmic imaging system for the viewing and axial cross sectional imaging of posterior ocular structures. It is used for in vivo imaging of the retinal nerve fiber layer and optic disc. It is intended for use as a diagnostic device to aid in the detection and management of ocular diseases, including but not limited to macular edema and central serous retinopathy.
Device Story
Non-contact ophthalmic imaging system; utilizes optical coherence tomography (OCT) via interferometry of superluminescent diode light reflected from the fundus. Captures axial cross-sectional images of posterior ocular structures; specifically retina, retinal nerve fiber layer, and optic disc. System comprises main unit with optical systems, power supply, chin rest, and spectroscope; connects to PC for image viewing/analysis. Operated by eye care professionals in clinical settings. Provides high-resolution tomograms to assist clinicians in diagnosing and managing ocular pathologies like macular edema and central serous retinopathy. Benefits include non-invasive visualization of retinal layers to support clinical decision-making.
Clinical Evidence
Bench testing only. Comparative study of 55 image pairs from 31 eyes (normal, macular holes, CME, ERM, AMD) obtained using subject and predicate devices. Two independent graders evaluated images against predefined diagnostic criteria. Subject device met or exceeded predicate image quality in 100% of cases (110/110 scorings). Maximum light exposure confirmed below IEC 60825-1:2001 limits.
Technological Characteristics
Optical coherence tomography (OCT) using superluminescent diode light source; interferometry-based imaging. Components: main unit with three optical systems, power supply, chin rest, spectroscope, and PC connectivity. Digital signal processing (DSP) for interferometric signal conversion to tomograms. Complies with IEC 60825-1:2001 for laser safety.
Indications for Use
Indicated for in vivo imaging of the retina, retinal nerve fiber layer, and optic disc in patients to aid in the detection and management of ocular diseases, including macular edema and central serous retinopathy.
Regulatory Classification
Identification
An ophthalmoscope is an AC-powered or battery-powered device containing illumination and viewing optics intended to examine the media (cornea, aqueous, lens, and vitreous) and the retina of the eye.
Special Controls
*Classification.* Class II (special controls). The device, when it is an AC-powered opthalmoscope, a battery-powered opthalmoscope, or a hand-held ophthalmoscope replacement battery, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.
Predicate Devices
- Carl Zeiss, Inc., Humphrey OCT Scanner
- Carl Zeiss Ophthalmic Systems, Inc.'s, Humphrey OCT 3
Related Devices
- K083316 — 3D OCT-1000 MARK II OPTICAL COHERENCE TOMOGRAPHY SYSTEM · Topcon Medical Systems, Inc. · Mar 13, 2009
- K092470 — OPTICAL COHERENCE TOMOGRAPHY 3D OCT-2000 · Topcon Corp. · Sep 2, 2009
- K072971 — TOPCON 3D OCT-1000 OPTICAL COHERENCE TOMOGRAPHY SYSTEM FOR MEASUREMENT OF RETINAL THICKNESS · Topcon Medical Systems, Inc. · Jan 13, 2009
- K083291 — CIRRUS HD-OCT WITH RETINAL NERVE FIBER LAYER AND MACULAR NORMATIVE DATABASES, MODEL 4000 · Carl Zeiss Meditec, Inc. · May 5, 2009
- K231222 — 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2) · Topcon Corporation · Oct 30, 2023
Submission Summary (Full Text)
{0}------------------------------------------------
K063388
## 510(k) SUMMARY
JUN 2 2 2 2007
# Topcon Corporation's 3D OCT-1000 Optical Coherence Tomography System
Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared
Topcon Corporation 75-1 Hasunuma-cho, Itabashi-ku Tokyo, Japan 174
## Additional Correspondents:
Topcon Medical System, Inc. 37 West Century Road Paramus, NJ 07652 Phone: (201) 599-5153 Facsimile: (201) 599-5240 Beth Zelnick Kaufman Contact Person:
OR
Jonathan S. Kahan Hogan & Hartson, L.L.P. 555 Thirteenth Street, NW Washington, DC 20004 (202) 637-5794 Phone: Facsimile: (202) 637-5910
Date Prepared: November 8, 2006
#### Name of Device and Name/Address of Sponsor
Topcon 3D OCT-1000 Optical System Tomography System
Topcon Corporation 75-1 Hasunuma-cho, Itabashi-ku Tokyo, Japan 174
{1}------------------------------------------------
# Common or Usual Name
AC- Powered Ophthalmoscope
#### Classification Name
Ophthalmoscope; 21 C.F.R. 886.1570
#### Predicate Devices
Carl Zeiss. Inc., Humphrey OCT Scanner Carl Zeiss Ophthalmic Systems, Inc.'s, Humphrey OCT 3
## Intended Use / Indications for Use
The Topcon 3D OCT-1000 is a non-contact ophthalmic imaging system for the viewing and axial cross sectional imaging of posterior ocular structures. It is used for in vivo imaging of the retinal nerve fiber layer and optic disc. It is intended for use as a diagnostic device to aid in the detection and management of ocular diseases, including but not limited to macular edema and central serous retinopathy.
## Technological Characteristics
Both the Topcon 3D OCT-1000 and the predicate devices have similar technological characteristics. The Topcon 3D OCT-1000 and the predicate devices use optical coherence tomography, which relies upon interferometry of superluminescent diode light reflected from the fundus of the eye to obtain cross-sectional images of the retina.
In addition, both the Topcon 3D OCT-1000 and the predicate devices have similar components. The components of the Topcon 3D OCT-1000 include a Main Unit, which houses three optical systems for observing and photographing the retina, a Power Supply Unit, a chin rest, a Spectroscope, and the ability to connect a personal computer for image viewing and analysis. Similarly, the Carl Zeiss, Inc. Humphrey OCT Scanner the Carl Zeiss Ophthalmic Systems, Inc.'s, Humphrey OCT 3 utilize optical systems for observing and photographing the retina, a digital signal processing (DSP) unit for obtaining interferometric signal and converting to retinal tomograms, a chin rest, and connection to a computer for viewing and analyzing captured images.
{2}------------------------------------------------
The Topcon 3D OCT-1000 also uses similar light sources as the Carl Zeiss, Inc. Humphrey OCT Scanner and the Carl Zeiss Ophthalmic Systems, Inc.'s, Humphrey OCT 3, and thus has optical equivalency.
# Performance Data
The maximum exposure has been demonstrated to be well below the accepted threshold limits set out in IEC 60825-1:2001. In all instances, the Topcon 3D OCT-1000 functioned as intended.
In total, Topcon collected 55 images from 31 eyes, including at least seven pairs each from subjects with normal eyes, macular holes, cystoid macular edema (CME) and epiretinal membrane (ERM), as well as both dry and wet form age-related macular degeneration. All images were obtained using both the 3D OCT-1000 device and a predicate device. Paired images were independently graded by two graders using predefined diagnostic image criteria. In all of the 55 pairs of images, the graders (with the consensus score) demonstrated that the Topcon image met as many or more image criteria to support a diagnostic use of the image than the predicate device image. Specifically, the Topcon image was scored as meeting the same number of image quality criteria to support its diagnostic use in 81 of the 110 scorings, and as meeting more of the predefined criteria in 29 of the 110 scorings. Thus, the Topcon image met the same or more criteria than the predicate device image for an overall agreement of 100% (110 of 110 images).
#### Substantial Equivalence
The Topcon 3D OCT-1000 is as safe and effective as the Carl Zeiss. Inc., Humphrey OCT Scanner and the Carl Zeiss Ophthalmic Systems, Inc.'s, Humphrey OCT 3. The Topcon 3D OCT-1000 has the same intended uses and similar indications, technological characteristics, and principles of operation as its predicate device. The minor technological differences between the 3D OCT-1000 and its predicate devices raise no new issues of safety or effectiveness. Performance data demonstrate that the Topcon 3D OCT is as safe and effective as the Carl Zeiss Humphrey OCT device. Thus, the 3D OCT-1000 is substantially equivalent.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circle around the eagle. The text is in all caps and is written in a simple, sans-serif font. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Topcon Corporation c/o Hogan & Hartson LLP 555 Thirteenth St NW Columbia Square Washington, DC 20004 Attn: Jonathan Kahan
JUN 2 2 2007
Re: K063388
Trade/Device Name: 3D OCT-1000 Optical Coherence Tomography System Regulation Number: 21 CFR 886.1570 Regulation Name: Ophthalmoscope, AC-Powered Regulatory Class: Class II Product Code: OBO Dated: May 23, 2007 Received: May 23, 2007
Dear Mr. Kahan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the iddications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the 1 ct . The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration,
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, WA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{4}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will and w yourse FDA finding of substantial equivalence of your device to a legally prematication. The PDF interest in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please if you don't operio an Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small other general international and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
M.B. Eglemer SimWD
Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Indications for Use Statement
| 510(k) Number (if known): | K06388 |
|---------------------------|--------|
|---------------------------|--------|
Device Name: Topcon 3D OCT-1000
Indications for Use:
The Topcon 3D OCT-1000 is a non-contact ophthalmic imaging system for the viewing and axial cross sectional imaging of posterior ocular structures. It is used for in vivo imaging of the retina, retinal nerve fiber layer and optic disc. It is intended for use as a diagnostic device to aid in the detection and management of ocular diseases, including but not limited to macular edema and central serous retinopathy.
Prescription Use _ X (Part 21 C.F.R. 801 Subpart D) AND/OR
Over-The-Counter Use (21 C.F.R. 807 Subpart C)
# (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Clay R. Bitty
of **Ophthalmic Ear,**
and **Throat Devises**
) Number K063388
Page _________________________________________________________________________________________________________________________________________________________________________
\\\DC - 026811/000002 - 2390063 v1